1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience
By J. Winter, John L. Cameron, K. Campbell, Meghan A. Arnold, D. Chang, J. Coleman, Mary B. Hodgin, P. Sauter, R. Hruban, T. Riall and 4 more. Journal of Gastrointestinal Surgery, 2006
1,463 citations recorded by the source corpus.
Subfields: Epidemiology, Oncology, Surgery
View Paper: https://www.semanticscholar.org/paper/dac3e973b0dfde57c25c29bcb0eb50c9da45e4c4
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Oncology
Citations in the corpus
- Prevalence of unsuspected pancreatic cysts on MDCT. (2008, background): “Detection of this disease in its early curable stages is difficult, to the extent that more than 80% of pancreatic cancers have metastasized or are locally unresectable at the time of diagnosis [2].”
- Recent progress in pancreatic cancer (2013, background): “Cancers arising in the head of the pancreas require a pancreaticoduodenectomy (Whipple operation), whereas those in the tail require a distal pancreatectomy with an en bloc splenectomy.(131) Lesions located in the neck and body may require a pancreaticoduodenectomy, distal pancreatectomy or, rarely,”
- Advanced pancreatic carcinoma: current treatment and future challenges (2010, background): “Perineural, vascular and lymphatic invasion are commonly observed in resected tumor specimens; lymph-node metastases are present in 50–75% of resected cases”
- DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. (2009, background): “Thus, 80% of patients with pancreatic cancer have advanced stage disease at diagnosis and are not candidates for surgical intervention.(2,3) A recent study indicated an alarming reluctance in the medical community to proceed to potentially curative surgery in patients with early-stage pancreatic can”
- A Six-Gene Signature Predicts Survival of Patients with Localized Pancreatic Ductal Adenocarcinoma (2010, background): “, only two have found that adjuvant therapy was associated with improved survival”